SNAP-8

SNAP-8 (Acetyl Octapeptide-3) is a synthetic octapeptide designed to modulate the SNARE (Soluble NSF Attachment Protein Receptor) complex, the molecular machinery responsible for synaptic vesicle fusion and neurotransmitter release at the neuromuscular junction. SNAP-8 is based on a fragment of the SNAP-25 protein, one of the three SNARE complex components (along with syntaxin-1 and VAMP-2/synaptobrevin). By mimicking a portion of SNAP-25, SNAP-8 has been investigated for its ability to compete with native SNAP-25 for incorporation into the SNARE complex, potentially reducing the efficiency of synaptic vesicle fusion and neurotransmitter exocytosis. SNAP-8 is an extension of the SNAP-6 (Argireline/Acetyl Hexapeptide-3) concept, with two additional amino acids to improve SNARE complex interaction. It is widely studied in the cosmetic peptide and neuromuscular biology research fields.

SNAP-8 has been investigated for its modulation of SNARE complex assembly at the neuromuscular junction. The SNARE complex is a four-helix bundle formed by SNAP-25 (contributing two helices), syntaxin-1 (one helix), and VAMP-2 (one helix) that provides the mechanical force for synaptic vesicle fusion with the presynaptic membrane and acetylcholine release. Researchers have studied SNAP-8 as a competitive fragment of SNAP-25 that integrates into partially assembled SNARE complexes, reducing the efficiency of full complex formation and vesicle fusion. Studies in neuromuscular biology models suggest that reduced SNARE complex efficiency decreases the quantum of acetylcholine released per nerve impulse, attenuating muscle contraction force. This mechanism is conceptually similar to, but much milder than, botulinum toxin’s proteolytic cleavage of SNAP-25. In cellular exocytosis assays, researchers observed that SNAP-8 treatment was associated with dose-dependent reductions in catecholamine and neurotransmitter release markers.

SNARE Complex Biology

Söllner et al. (1993) characterized the SNARE complex and the role of SNAP-25 in synaptic vesicle fusion, providing the molecular biology foundation for SNAP-8’s design [1].

Cosmetic Peptide Activity

Blanes-Mira et al. (2002) characterized the mechanism of SNAP-25-derived peptides in neuromuscular models, demonstrating competitive SNARE complex modulation as the basis for reduced neurotransmitter release [2].

Exocytosis Modulation

Zhang et al. (2009) investigated acetyl octapeptide-3 in chromaffin cell models and observed dose-dependent reductions in catecholamine release, confirming SNARE complex-mediated exocytosis modulation [3].